This checklist helps you figure out if you need more time and support
Semaglutide is a once-weekly GLP-1 receptor agonist indicated for: Improving glycemic control in adults with Type 2 Diabetes Mellitus Chronic weight management in eligible patients, alongside a reduced-calorie diet and increased physical activity We are proud to expand our specialty injectable portfolio with a product manufactured to high-quality standards for global markets
Indications and Usage Wegovy (semaglutide) injection is indicated in combination with a reduced calorie diet and increased physical activity: To reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight To reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients 12 years and older with obesity Adults with overweight in the presence of at least one weight-related comorbidity Wegovy (semaglutide) tablets are indicated in combination with a reduced calorie diet and increased physical activity to: Reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight Reduce excess body weight and maintain weight reduction long term in adults with obesity or with overweight in the presence of at least one weight-related comorbidity Limitations of Use: Concomitant use of Wegovy tablets or Wegovy injection with other semaglutide-containing products or with any GLP-1 receptor agonist is not recommended References Simmonds M, Llewellyn A, Owen CG, Woolacott N
They can also suggest suitable laxatives if needed and offer guidance on safe use
Regular exercise is also important, as it helps to burn calories and build muscle
